New 6-bromoimidazo[1,2-A]pyridine-2-carbohydrazide derivatives: Synthesis and anticonvulsant studies

dc.contributor.authorUlloora, S.
dc.contributor.authorShabaraya, R.
dc.contributor.authorVasudeva Adhikari, A.V.
dc.date.accessioned2026-02-05T09:34:30Z
dc.date.issued2014
dc.description.abstractIn the present work, we report the facile synthesis and anticonvulsant study of new imidazo[1,2-A]pyridines carrying biologically active hydrazone functionality (3a-3e) and suitably substituted 1,2,4-triazole moieties (4, 5a-5d, 6, and 7a-7d). The newly synthesized intermediates and final compounds were characterized by various spectral techniques such as FTIR, 1H NMR, 13C NMR, and mass spectral and elemental analysis studies. The in vivo anticonvulsant study of the target compounds were carried out following maximal electroshock seizure and subcutaneous pentylene tetrazole methods, while their toxicity study was performed following rotarod method by taking 20, 40, and 100 mg/kg dose levels. Most of the new compounds displayed remarkable anticonvulsant properties at these doses. Particularly, compounds 3b and 4 carrying hydrogen bond donor groups, viz. hydroxyl and amine moieties respectively, exhibited complete protection against seizure and their results are comparable to that of standard drug diazepam. Further, the motor impairment study revealed that all the compounds are nontoxic upto 100 mg/kg. © 2013 Springer Science+Business Media New York.
dc.identifier.citationMedicinal Chemistry Research, 2014, 23, 6, pp. 3019-3028
dc.identifier.issn10542523
dc.identifier.urihttps://doi.org/10.1007/s00044-013-0887-7
dc.identifier.urihttps://idr.nitk.ac.in/handle/123456789/26639
dc.publisherBirkhauser Boston
dc.subject2 [5 (4 methoxybenzylthio) 4 phenyl 4h 1,2,4 triazol 3 yl] 6 bromoimidazo[1,2 a]pyridine
dc.subject2 [5 (4 nitrobenzylthio) 4 phenyl 4h 1,2,4 triazol 3 yl) 6 bromoimidazo[1,2 a]pyridine
dc.subject2 [5 (benzylthio) 4 phenyl 4h 1,2,4 triazol 3 yl] 6 bromoimidazo[1,2 a]pyridine
dc.subject4 (4 fluorobenzylideneamino) 5 (6 bromoimidazo[1,2 a] pyridin 2 yl) 4h 1,2,4 triazole 3 thiol
dc.subject4 (4 methylbenzylideneamino] 5 (6 bromoimidazo[1,2 a] pyridin 2 yl) 4h 1,2,4 triazole 3 thiol
dc.subject4 (4 nitrobenzylideneamino) 5 (6 bromoimidazo[1,2 a] pyridin 2 yl) 4h 1,2,4-triazole 3 thiol
dc.subject4 amino 5 (6 bromoimidazo[1,2 a]pyridin 2 yl) 4h 1,2, 4 triazole 3 thiol
dc.subject4 [[3 (6 bromoimidazo[1,2 a]pyridin 2 yl) 5 mercapto 4h 1,2,4 triazol 4 ylimino]methyl]phenol
dc.subject5 (6 bromoimidazo[1,2 a] pyridin 2 yl) 4 phenyl 4h 1,2,4 triazole 3 thiol
dc.subject6 bromo 2 (4 phenyl 5 (propylthio) 4h 1,2,4 triazol 3 yl) imidazo[1,2 a]pyridine
dc.subject6 bromo n' (thiophen 2 ylmethylene)imidazo[1,2 a] pyridine 2 carbohydrazide
dc.subjectanticonvulsive agent
dc.subjectdiazepam
dc.subjecthydrazide derivative
dc.subjectn' (4 fluorobenzylidene) 6 bromoimidazo[1,2 a] pyridine 2 carbohydrazide
dc.subjectn' (4 hydroxy 3 methoxybenzylidene) 6 bromoimidazo [1,2 a]pyridine 2 carbohydride
dc.subjectn' (4 hydroxybenzylidene) 6 bromoimidazo[1,2 a] pyridine 2 carbohydrazide
dc.subjectn' (4 nitrobenzylidene) 6 bromoimidazo[1,2 a]pyridine 2 carbohydrazide
dc.subjectpentetrazole
dc.subjectphenytoin
dc.subjectunclassified drug
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanticonvulsant activity
dc.subjectarticle
dc.subjectcarbon nuclear magnetic resonance
dc.subjectcontrolled study
dc.subjectdrug synthesis
dc.subjectelectroshock seizure
dc.subjecthydrogen bond
dc.subjectin vivo study
dc.subjectinfrared spectroscopy
dc.subjectmass spectrometry
dc.subjectmouse
dc.subjectneuroprotection
dc.subjectnonhuman
dc.subjectproton nuclear magnetic resonance
dc.subjectrotarod test
dc.subjecttoxicity testing
dc.titleNew 6-bromoimidazo[1,2-A]pyridine-2-carbohydrazide derivatives: Synthesis and anticonvulsant studies

Files

Collections